Advertisement

Internal Medicine

Home Internal Medicine
For adults with congenital heart disease

Readmit Predictors for Congenital Heart Disease Are Lesion Specific

Readmission more likely with primary diagnosis of congestive heart failure at index admission
The average annual premiums for single and family coverage remained stable in 2016

Average Premiums for Health Care Coverage Stable in 2016

Family premium 3 percent higher in 2016 than 2015; no change in share of firms offering health benefits
Interleukin-32 has inflammatory and remodeling properties in human obesity

IL-32 Has Inflammatory Properties in Human Obesity

Increased circulating IL-32 in obese patients down after Roux-en-Y gastric bypass-linked weight loss
Women who consume high amounts of meat

Fatty Acid Consumption Tied to T2DM Risk in Women

Findings for arachidonic acid, docosapentaenoic acid, and alpha-linolenic acid
Pokémon GO is becoming a dangerous distraction for drivers

Playing Pokémon GO Leading to Increase in Distracted Driving

At least 14 crashes linked to the smartphone game during a 10-day period in July
A new sound-based therapy appears to reduce blood pressure and ease migraine symptoms

Sound-Based Therapy Can Reduce Blood Pressure, Ease Migraine

Sound therapy balances brain signals, researcher says
For American-Indians with type 2 diabetes

Early Rx With Losartan Doesn’t Slow Kidney Disease Progression

Findings in American-Indians with type 2 diabetes and urine albumin/creatinine ratio <300 mg/g
Advising patients with asthma to take probiotics does not reduce antibiotic use

Recommending Oral Probiotics Doesn’t Cut Antibiotic Use

Advice to take probiotics has no effect for patients with asthma in U.K. primary care setting
For patients with chronic chilblains

Nifedipine Not Superior to Placebo for Chronic Chilblains

No significant improvements in mean visual analogue scale scores on complaints, disability
For hypogonadal men with prostate cancer

Testosterone Seems Safe for Hypogonadal Prostate CA Patients

Testosterone therapy seems oncologically safe after treatment or for those on active surveillance